Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects

OBJECTIVE: To confirm the efficacy and safety of incobotulinumtoxinA (Xeomin®, Merz Pharmaceuticals GmbH; total dose 400 U) in Japanese subjects with lower limb (LL) poststroke spasticity using the Modified Ashworth Scale spasticity score for the plantar flexors (MAS-PF). METHODS: This phase III stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Masakado, Yoshihisa, Kagaya, Hitoshi, Kondo, Kunitsugu, Otaka, Yohei, Dekundy, Andrzej, Hanschmann, Angelika, Geister, Thorin L., Kaji, Ryuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970182/
https://www.ncbi.nlm.nih.gov/pubmed/35370917
http://dx.doi.org/10.3389/fneur.2022.832937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970182/
https://www.ncbi.nlm.nih.gov/pubmed/35370917
http://dx.doi.org/10.3389/fneur.2022.832937

Ejemplares similares